Complete Omics is a Baltimore, Maryland based, CLIA- and CAP-accredited molecular diagnostics company building ultra-deep, clinically reproducible proteomics and multi-omics testing. Its Complete360 liquid- and tissue-biopsy platform and Valid-NEO companion-diagnostics platform apply AI-assisted analysis of high-dimensional biological data across oncology, neurology, cardiovascular, and immunology testing. The company holds 40+ global patents and 20+ top-tier journal publications. Complete Omics is a portfolio company of Qiming Venture Partners. No public developer API, documentation, or SDK surface exists at this time; this profile captures company identity and domain-security posture.
Complete Omics is profiled on the APIs.io network. Tagged areas include Company, Molecular Diagnostics, Proteomics, Multiomics, and Genomics.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.